Home/ Supplements/ Niacin/ Cholesterol Care

Cholesterol Care

product on market Tablet or Pill Healthy Choice Naturals Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 14% of ingredients have research evidence
B Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

This profile includes red rice extract and beta-glucan, which have strong evidence for lowering LDL cholesterol. Guggulipid and beta-sitosterol provide moderate support for lipid management, while niacin is traditionally used for triglyceride reduction. Research indicates these ingredients collectively target various cholesterol pathways.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Cholesterol Care
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Tablet(s)
Serving Size
30
Servings
Other Combinations
Product Type
14%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

20 mg (100% DV)
1.4× RDA — within safe limits 196 studies (A:5, B:63)
Guggulipid
1000 mg
Red Rice Extract
700 mg
Beta-Sitosterol
300 mg
Beta Glucan
50 mg
Policosanol
3 mg

Other Ingredients

Dicalcium Phosphate Cellulose Croscarmellose Sodium Stearic Acid Silicon Dioxide Magnesium Stearate Pharmaceutical Glaze
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Suggested Use: Adults - Take 2 tablets daily before meals, one in the morning and one in the evening as a food supplement.

Warnings & Precautions

Caution: Do not exceed recommended dose.

Pregnant or nursing mothers, children under 18 and individuals with a known medical condition should consult a physician before using this or any dietary supplement.

Pregnant or nursing mothers, children under 18 and individuals with a known medical condition should consult a physician before using this or any dietary supplement. Keep out of reach of children.

Do not use if safety seal is damaged or missing.

Allergen Warning: Contains soy (beta-sitosterol)

Formulation Notes

Contains beta-sitosterol and guggul lipids

All natural formula with beta-sitosterol and guggul lipids

Allergen Warning: Contains soy (beta-sitosterol)

Additional Information

All-natural ingredients

Store in a cool, dry place.

SKU: CHOLCARE v5.4

Made in USA

Cholesterol support formula

v5.4

Metadata

Product Details

UPC / SKU8 50004 00102 8
DSLD Entry Date2017-03-24
Product TypeOther Combinations
FormTablet or Pill
DSLD ID71943
Data Updated2026-04-11
Research

Research Evidence

241
Research Sources
55
Avg Quality
113
Meta Analysis
75
Systematic Review
32
Rct
11
Clinical Trial
3
Other
3
Regulatory Source
1
Cochrane Review
1
Narrative Review
1
Openfda Safety
A Niacin for primary and secondary prevention of cardiovascular events
Meta Analysis The Cochrane database of systematic reviews 2017 PubMed DOI
A Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases
Meta Analysis BMJ (Clinical research ed.) 2013 PubMed DOI
A Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117,411 patients
Meta Analysis BMJ (Clinical research ed.) 2014 PubMed DOI
A A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk
Meta Analysis Nature medicine 2024 PubMed DOI
A Meta-analysis and imputation refines the association of 15q25 with smoking quantity
Meta Analysis Nature genetics 2010 PubMed DOI
A Genome-wide meta-analyses identify multiple loci associated with smoking behavior
Meta Analysis Nature genetics 2010 PubMed DOI
A Antidepressants for smoking cessation
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
A Topical azelaic acid, salicylic acid, nicotinamide, sulphur, zinc and fruit acid (alpha-hydroxy acid) for acne
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
B Assessment of the Role of Niacin in Managing Cardiovascular Disease Outcomes: A Systematic Review and Meta-analysis
Meta Analysis JAMA network open 2019 PubMed DOI
B Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions: A Systematic Review and Meta-analysis
Meta Analysis JAMA 2016 PubMed DOI
View all evidence for Niacin →
Compare

Similar Products

View all Niacin products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.